Efficacy of Olopatadine versus Epinastine for Treating Allergic Conjunctivitis Caused by Japanese Cedar Pollen: A Double-Blind Randomized Controlled Trial

被引：0
作者：
Atsuki Fukushima
Nobuyuki Ebihara
机构：
[1] Kochi Medical School,Department of Ophthalmology
[2] Juntendo University School of Medicine,Department of Ophthalmology
来源：
Advances in Therapy | 2014年 / 31卷
关键词：
Allergic conjunctivitis; Conjunctival allergen challenge; CAC; Conjunctival hyperemia; Epinastine; Itching; Japanese cedar pollen; Olopatadine; Ophthalmology;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1045 / 1058
页数：13
相关论文
共 32 条
  • [1] Efficacy of Olopatadine versus Epinastine for Treating Allergic Conjunctivitis Caused by Japanese Cedar Pollen: A Double-Blind Randomized Controlled Trial
    Fukushima, Atsuki
    Ebihara, Nobuyuki
    ADVANCES IN THERAPY, 2014, 31 (10) : 1045 - 1058
  • [2] Alcaftadine 0.25% versus Olopatadine 0.1% in Preventing Cedar Pollen Allergic Conjunctivitis in Japan: A Randomized Study
    Nakatani, Hiroshi
    Gomes, Paul
    Bradford, Ron
    Guo, Qiang
    Safyan, Eleonora
    Hollander, David A.
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2019, 27 (04) : 622 - 631
  • [3] Effects of probiotics on allergic rhinitis induced by Japanese cedar pollen: Randomized double-blind, placebo-controlled clinical trial
    Tamura, Manabu
    Shikina, Takashi
    Morihana, Tetsuo
    Hayama, Masaki
    Kajimoto, Osami
    Sakamoto, Akane
    Kajimoto, Yoshitaka
    Watanabe, Osamu
    Nonaka, Chiaki
    Shida, Kan
    Nanno, Masanobu
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2007, 143 (01) : 75 - 82
  • [4] Efficacy of oral olopatadine hydrochloride for the treatment of seasonal allergic rhinitis: A randomized, double-blind, placebo-controlled study
    Yamamoto, Hideyuki
    Yamada, Takechiyo
    Kubo, Seita
    Osawa, Yoko
    Kimura, Yuichi
    Oh, Myonmi
    Susuki, Dai
    Takabayashi, Tetsuji
    Okamoto, Masayuki
    Fujieda, Shigeharu
    ALLERGY AND ASTHMA PROCEEDINGS, 2010, 31 (04) : 296 - 303
  • [5] Efficacy of Desloratadine and Levocetirizine in Patients with Cedar Pollen-Induced Allergic Rhinitis: A Randomized, Double-Blind Study
    Yonekura, Syuji
    Okamoto, Yoshitaka
    Sakurai, Daiju
    Iinuma, Tomohisa
    Sakurai, Toshioki
    Yoneda, Riyo
    Kurita, Junya
    Hanazawa, Toyoyuki
    Kawasaki, Yohei
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2019, 180 (04) : 274 - 283
  • [6] A randomized, double-blind, parallel-group comparison of olopatadine 0.1% ophthalmic solution versus placebo for controlling the signs and symptoms of seasonal allergic conjunctivitis and rhinoconjunctivitis
    Abelson, MB
    Turner, D
    CLINICAL THERAPEUTICS, 2003, 25 (03) : 931 - 947
  • [7] Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial
    Borazan, Mehmet
    Karalezli, Aylin
    Akova, Yonca Aydin
    Akman, Ahmet
    Kiyici, Halil
    Erbek, Selim S.
    ACTA OPHTHALMOLOGICA, 2009, 87 (05) : 549 - 554
  • [8] Efficacy and tolerability of ophthalmic epinastine: A randomized, double-masked, parallel-group, active- and vehicle-controlled environmental trial in patients with seasonal allergic conjunctivitis
    Whitcup, SM
    Bradford, R
    Lue, J
    Schiffman, RM
    Abelson, MB
    CLINICAL THERAPEUTICS, 2004, 26 (01) : 29 - 34
  • [9] Azelastine eye-drops in seasonal allergic conjunctivitis or rhinoconjunctivitis - A double-blind, randomized, placebo-controlled study
    Giede-Tuch, C
    Westhoff, M
    Zarth, A
    ALLERGY, 1998, 53 (09) : 857 - 862
  • [10] Efficacy of Alcaftadine 0.25% (AGN-229666) for Once-daily Prevention of Cedar-Pollen Allergic Conjunctivitis: A Phase 3 Randomized Study
    Fujishima, Hiroshi
    Hasunuma, Tomoko
    Kawakita, Tetsuya
    Sekiya, Takuro
    Gomes, Paul
    Hollander, David A.
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2021, 29 (7-8) : 1621 - 1626
1234